nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Vandetanib—thyroid cancer	0.124	0.508	CbGbCtD
Darunavir—CYP3A4—Sorafenib—thyroid cancer	0.0748	0.306	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—thyroid cancer	0.0454	0.186	CbGbCtD
Darunavir—Abdominal pain—Sorafenib—thyroid cancer	0.000841	0.00111	CcSEcCtD
Darunavir—Body temperature increased—Sorafenib—thyroid cancer	0.000841	0.00111	CcSEcCtD
Darunavir—Renal impairment—Epirubicin—thyroid cancer	0.00084	0.00111	CcSEcCtD
Darunavir—Eczema—Doxorubicin—thyroid cancer	0.000824	0.00109	CcSEcCtD
Darunavir—Hepatic failure—Doxorubicin—thyroid cancer	0.000824	0.00109	CcSEcCtD
Darunavir—Hypoglycaemia—Epirubicin—thyroid cancer	0.00082	0.00108	CcSEcCtD
Darunavir—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000816	0.00108	CcSEcCtD
Darunavir—Lethargy—Epirubicin—thyroid cancer	0.000816	0.00108	CcSEcCtD
Darunavir—Hyponatraemia—Epirubicin—thyroid cancer	0.000803	0.00106	CcSEcCtD
Darunavir—Renal failure acute—Doxorubicin—thyroid cancer	0.000802	0.00106	CcSEcCtD
Darunavir—Pain in extremity—Epirubicin—thyroid cancer	0.0008	0.00106	CcSEcCtD
Darunavir—Increased appetite—Doxorubicin—thyroid cancer	0.000788	0.00104	CcSEcCtD
Darunavir—Affect lability—Epirubicin—thyroid cancer	0.000787	0.00104	CcSEcCtD
Darunavir—Hypersensitivity—Sorafenib—thyroid cancer	0.000784	0.00104	CcSEcCtD
Darunavir—Renal impairment—Doxorubicin—thyroid cancer	0.000778	0.00103	CcSEcCtD
Darunavir—Asthenia—Sorafenib—thyroid cancer	0.000763	0.00101	CcSEcCtD
Darunavir—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000758	0.001	CcSEcCtD
Darunavir—Mood swings—Epirubicin—thyroid cancer	0.000758	0.001	CcSEcCtD
Darunavir—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000755	0.000999	CcSEcCtD
Darunavir—Lethargy—Doxorubicin—thyroid cancer	0.000755	0.000999	CcSEcCtD
Darunavir—Pruritus—Sorafenib—thyroid cancer	0.000753	0.000996	CcSEcCtD
Darunavir—Blood creatinine increased—Epirubicin—thyroid cancer	0.000749	0.000992	CcSEcCtD
Darunavir—Hyponatraemia—Doxorubicin—thyroid cancer	0.000743	0.000983	CcSEcCtD
Darunavir—Pain in extremity—Doxorubicin—thyroid cancer	0.00074	0.000979	CcSEcCtD
Darunavir—Liver function test abnormal—Epirubicin—thyroid cancer	0.000738	0.000977	CcSEcCtD
Darunavir—Dry skin—Epirubicin—thyroid cancer	0.000733	0.00097	CcSEcCtD
Darunavir—Affect lability—Doxorubicin—thyroid cancer	0.000728	0.000964	CcSEcCtD
Darunavir—Diarrhoea—Sorafenib—thyroid cancer	0.000728	0.000963	CcSEcCtD
Darunavir—Breast disorder—Epirubicin—thyroid cancer	0.000723	0.000956	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00072	0.000953	CcSEcCtD
Darunavir—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00072	0.000953	CcSEcCtD
Darunavir—Nasopharyngitis—Epirubicin—thyroid cancer	0.000715	0.000946	CcSEcCtD
Darunavir—Gastritis—Epirubicin—thyroid cancer	0.000708	0.000937	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000705	0.000933	CcSEcCtD
Darunavir—Muscular weakness—Epirubicin—thyroid cancer	0.000705	0.000933	CcSEcCtD
Darunavir—Dizziness—Sorafenib—thyroid cancer	0.000703	0.000931	CcSEcCtD
Darunavir—Mood swings—Doxorubicin—thyroid cancer	0.000701	0.000928	CcSEcCtD
Darunavir—Abdominal distension—Epirubicin—thyroid cancer	0.000696	0.000921	CcSEcCtD
Darunavir—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000693	0.000917	CcSEcCtD
Darunavir—Eosinophilia—Epirubicin—thyroid cancer	0.000684	0.000906	CcSEcCtD
Darunavir—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000683	0.000904	CcSEcCtD
Darunavir—Dry skin—Doxorubicin—thyroid cancer	0.000678	0.000898	CcSEcCtD
Darunavir—Pancreatitis—Epirubicin—thyroid cancer	0.000678	0.000897	CcSEcCtD
Darunavir—Vomiting—Sorafenib—thyroid cancer	0.000676	0.000895	CcSEcCtD
Darunavir—Angina pectoris—Epirubicin—thyroid cancer	0.000673	0.000891	CcSEcCtD
Darunavir—Rash—Sorafenib—thyroid cancer	0.000671	0.000887	CcSEcCtD
Darunavir—Dermatitis—Sorafenib—thyroid cancer	0.00067	0.000887	CcSEcCtD
Darunavir—Breast disorder—Doxorubicin—thyroid cancer	0.000669	0.000885	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000666	0.000882	CcSEcCtD
Darunavir—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000666	0.000882	CcSEcCtD
Darunavir—Headache—Sorafenib—thyroid cancer	0.000666	0.000882	CcSEcCtD
Darunavir—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000662	0.000876	CcSEcCtD
Darunavir—Pancytopenia—Epirubicin—thyroid cancer	0.000657	0.000869	CcSEcCtD
Darunavir—Gastritis—Doxorubicin—thyroid cancer	0.000655	0.000867	CcSEcCtD
Darunavir—Muscular weakness—Doxorubicin—thyroid cancer	0.000653	0.000864	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000653	0.000864	CcSEcCtD
Darunavir—Dysuria—Epirubicin—thyroid cancer	0.000646	0.000855	CcSEcCtD
Darunavir—Neutropenia—Epirubicin—thyroid cancer	0.000646	0.000855	CcSEcCtD
Darunavir—Abdominal distension—Doxorubicin—thyroid cancer	0.000644	0.000852	CcSEcCtD
Darunavir—Pollakiuria—Epirubicin—thyroid cancer	0.000639	0.000845	CcSEcCtD
Darunavir—Eosinophilia—Doxorubicin—thyroid cancer	0.000633	0.000838	CcSEcCtD
Darunavir—Nausea—Sorafenib—thyroid cancer	0.000632	0.000836	CcSEcCtD
Darunavir—Weight increased—Epirubicin—thyroid cancer	0.000629	0.000832	CcSEcCtD
Darunavir—Pancreatitis—Doxorubicin—thyroid cancer	0.000627	0.00083	CcSEcCtD
Darunavir—Weight decreased—Epirubicin—thyroid cancer	0.000625	0.000828	CcSEcCtD
Darunavir—Hyperglycaemia—Epirubicin—thyroid cancer	0.000624	0.000825	CcSEcCtD
Darunavir—Angina pectoris—Doxorubicin—thyroid cancer	0.000623	0.000824	CcSEcCtD
Darunavir—Infestation NOS—Epirubicin—thyroid cancer	0.000616	0.000816	CcSEcCtD
Darunavir—Infestation—Epirubicin—thyroid cancer	0.000616	0.000816	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000611	0.000809	CcSEcCtD
Darunavir—Pancytopenia—Doxorubicin—thyroid cancer	0.000607	0.000804	CcSEcCtD
Darunavir—Renal failure—Epirubicin—thyroid cancer	0.000606	0.000802	CcSEcCtD
Darunavir—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000604	0.000799	CcSEcCtD
Darunavir—Jaundice—Epirubicin—thyroid cancer	0.000601	0.000795	CcSEcCtD
Darunavir—Stomatitis—Epirubicin—thyroid cancer	0.000601	0.000795	CcSEcCtD
Darunavir—Dysuria—Doxorubicin—thyroid cancer	0.000598	0.000791	CcSEcCtD
Darunavir—Neutropenia—Doxorubicin—thyroid cancer	0.000598	0.000791	CcSEcCtD
Darunavir—Pollakiuria—Doxorubicin—thyroid cancer	0.000591	0.000782	CcSEcCtD
Darunavir—Haematuria—Epirubicin—thyroid cancer	0.000588	0.000778	CcSEcCtD
Darunavir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000583	0.000771	CcSEcCtD
Darunavir—Weight increased—Doxorubicin—thyroid cancer	0.000582	0.00077	CcSEcCtD
Darunavir—Epistaxis—Epirubicin—thyroid cancer	0.000581	0.000769	CcSEcCtD
Darunavir—Weight decreased—Doxorubicin—thyroid cancer	0.000579	0.000766	CcSEcCtD
Darunavir—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000577	0.000763	CcSEcCtD
Darunavir—Infestation NOS—Doxorubicin—thyroid cancer	0.00057	0.000755	CcSEcCtD
Darunavir—Infestation—Doxorubicin—thyroid cancer	0.00057	0.000755	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000565	0.000748	CcSEcCtD
Darunavir—Bradycardia—Epirubicin—thyroid cancer	0.000563	0.000745	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—thyroid cancer	0.000561	0.000742	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000559	0.00074	CcSEcCtD
Darunavir—Haemoglobin—Epirubicin—thyroid cancer	0.000556	0.000736	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—thyroid cancer	0.000556	0.000736	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—thyroid cancer	0.000556	0.000736	CcSEcCtD
Darunavir—Haemorrhage—Epirubicin—thyroid cancer	0.000553	0.000732	CcSEcCtD
Darunavir—Hepatitis—Epirubicin—thyroid cancer	0.000553	0.000732	CcSEcCtD
Darunavir—Hypoaesthesia—Epirubicin—thyroid cancer	0.000551	0.000729	CcSEcCtD
Darunavir—Urinary tract disorder—Epirubicin—thyroid cancer	0.000546	0.000723	CcSEcCtD
Darunavir—Oedema peripheral—Epirubicin—thyroid cancer	0.000545	0.000721	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—thyroid cancer	0.000544	0.00072	CcSEcCtD
Darunavir—Connective tissue disorder—Epirubicin—thyroid cancer	0.000544	0.00072	CcSEcCtD
Darunavir—Urethral disorder—Epirubicin—thyroid cancer	0.000542	0.000718	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000539	0.000714	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—thyroid cancer	0.000538	0.000712	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—thyroid cancer	0.000533	0.000706	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—thyroid cancer	0.000523	0.000692	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—thyroid cancer	0.000521	0.00069	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—thyroid cancer	0.000517	0.000684	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—thyroid cancer	0.000515	0.000681	CcSEcCtD
Darunavir—Flushing—Epirubicin—thyroid cancer	0.000514	0.00068	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—thyroid cancer	0.000514	0.00068	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—thyroid cancer	0.000512	0.000677	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—thyroid cancer	0.000512	0.000677	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000509	0.000674	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000506	0.000669	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—thyroid cancer	0.000504	0.000667	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000503	0.000666	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—thyroid cancer	0.000502	0.000664	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—thyroid cancer	0.000502	0.000664	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—thyroid cancer	0.0005	0.000661	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—thyroid cancer	0.000499	0.00066	CcSEcCtD
Darunavir—Chills—Epirubicin—thyroid cancer	0.000497	0.000657	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—thyroid cancer	0.000493	0.000653	CcSEcCtD
Darunavir—Alopecia—Epirubicin—thyroid cancer	0.000489	0.000647	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—thyroid cancer	0.000485	0.000641	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—thyroid cancer	0.000484	0.000641	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—thyroid cancer	0.000482	0.000637	CcSEcCtD
Darunavir—Erythema—Epirubicin—thyroid cancer	0.000482	0.000637	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—thyroid cancer	0.000478	0.000633	CcSEcCtD
Darunavir—Flushing—Doxorubicin—thyroid cancer	0.000475	0.000629	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—thyroid cancer	0.000475	0.000629	CcSEcCtD
Darunavir—Flatulence—Epirubicin—thyroid cancer	0.000475	0.000628	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—thyroid cancer	0.000472	0.000624	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—thyroid cancer	0.000465	0.000615	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—thyroid cancer	0.000463	0.000613	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—thyroid cancer	0.000462	0.000612	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000461	0.000611	CcSEcCtD
Darunavir—Chills—Doxorubicin—thyroid cancer	0.000459	0.000608	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—thyroid cancer	0.000452	0.000599	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—thyroid cancer	0.000449	0.000594	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—thyroid cancer	0.000447	0.000591	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—thyroid cancer	0.000446	0.00059	CcSEcCtD
Darunavir—Erythema—Doxorubicin—thyroid cancer	0.000446	0.00059	CcSEcCtD
Darunavir—Anaemia—Epirubicin—thyroid cancer	0.000445	0.000589	CcSEcCtD
Darunavir—Agitation—Epirubicin—thyroid cancer	0.000443	0.000586	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—thyroid cancer	0.000439	0.000581	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—thyroid cancer	0.000436	0.000578	CcSEcCtD
Darunavir—Malaise—Epirubicin—thyroid cancer	0.000434	0.000575	CcSEcCtD
Darunavir—Vertigo—Epirubicin—thyroid cancer	0.000433	0.000573	CcSEcCtD
Darunavir—Syncope—Epirubicin—thyroid cancer	0.000432	0.000572	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—thyroid cancer	0.000431	0.000571	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—thyroid cancer	0.000429	0.000567	CcSEcCtD
Darunavir—Palpitations—Epirubicin—thyroid cancer	0.000426	0.000563	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—thyroid cancer	0.000423	0.00056	CcSEcCtD
Darunavir—Cough—Epirubicin—thyroid cancer	0.00042	0.000556	CcSEcCtD
Darunavir—Convulsion—Epirubicin—thyroid cancer	0.000417	0.000552	CcSEcCtD
Darunavir—Hypertension—Epirubicin—thyroid cancer	0.000416	0.00055	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000414	0.000547	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—thyroid cancer	0.000412	0.000545	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—thyroid cancer	0.00041	0.000543	CcSEcCtD
Darunavir—Myalgia—Epirubicin—thyroid cancer	0.00041	0.000543	CcSEcCtD
Darunavir—Chest pain—Epirubicin—thyroid cancer	0.00041	0.000543	CcSEcCtD
Darunavir—Agitation—Doxorubicin—thyroid cancer	0.00041	0.000542	CcSEcCtD
Darunavir—Anxiety—Epirubicin—thyroid cancer	0.000409	0.000541	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000407	0.000539	CcSEcCtD
Darunavir—Discomfort—Epirubicin—thyroid cancer	0.000405	0.000536	CcSEcCtD
Darunavir—Malaise—Doxorubicin—thyroid cancer	0.000402	0.000532	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—thyroid cancer	0.000401	0.000531	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—thyroid cancer	0.0004	0.00053	CcSEcCtD
Darunavir—Syncope—Doxorubicin—thyroid cancer	0.0004	0.000529	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—thyroid cancer	0.000399	0.000528	CcSEcCtD
Darunavir—Confusional state—Epirubicin—thyroid cancer	0.000396	0.000525	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—thyroid cancer	0.000394	0.000521	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—thyroid cancer	0.000392	0.000518	CcSEcCtD
Darunavir—Cough—Doxorubicin—thyroid cancer	0.000389	0.000515	CcSEcCtD
Darunavir—Shock—Epirubicin—thyroid cancer	0.000387	0.000512	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—thyroid cancer	0.000386	0.000511	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—thyroid cancer	0.000386	0.00051	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—thyroid cancer	0.000385	0.000509	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—thyroid cancer	0.000385	0.000509	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—thyroid cancer	0.000384	0.000508	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—thyroid cancer	0.000382	0.000505	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—thyroid cancer	0.00038	0.000503	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—thyroid cancer	0.000379	0.000502	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—thyroid cancer	0.000379	0.000502	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—thyroid cancer	0.000379	0.000502	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—thyroid cancer	0.000378	0.0005	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000377	0.000499	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—thyroid cancer	0.000375	0.000496	CcSEcCtD
Darunavir—Anorexia—Epirubicin—thyroid cancer	0.000375	0.000496	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—thyroid cancer	0.000371	0.000491	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—thyroid cancer	0.000367	0.000485	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000358	0.000474	CcSEcCtD
Darunavir—Shock—Doxorubicin—thyroid cancer	0.000358	0.000474	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—thyroid cancer	0.000357	0.000472	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000356	0.000471	CcSEcCtD
Darunavir—Insomnia—Epirubicin—thyroid cancer	0.000356	0.00047	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—thyroid cancer	0.000355	0.00047	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—thyroid cancer	0.000353	0.000468	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—thyroid cancer	0.000353	0.000467	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000352	0.000465	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—thyroid cancer	0.00035	0.000464	CcSEcCtD
Darunavir—Somnolence—Epirubicin—thyroid cancer	0.00035	0.000462	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—thyroid cancer	0.000347	0.000459	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—thyroid cancer	0.000346	0.000458	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—thyroid cancer	0.000342	0.000452	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000339	0.000449	CcSEcCtD
Darunavir—Fatigue—Epirubicin—thyroid cancer	0.000339	0.000448	CcSEcCtD
Darunavir—Pain—Epirubicin—thyroid cancer	0.000336	0.000445	CcSEcCtD
Darunavir—Constipation—Epirubicin—thyroid cancer	0.000336	0.000445	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000331	0.000439	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—thyroid cancer	0.000329	0.000435	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—thyroid cancer	0.000327	0.000432	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—thyroid cancer	0.000324	0.000429	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—thyroid cancer	0.000324	0.000429	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—thyroid cancer	0.000323	0.000428	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000321	0.000425	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—thyroid cancer	0.00032	0.000424	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—thyroid cancer	0.000316	0.000418	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000314	0.000416	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—thyroid cancer	0.000314	0.000415	CcSEcCtD
Darunavir—Urticaria—Epirubicin—thyroid cancer	0.000312	0.000413	CcSEcCtD
Darunavir—Pain—Doxorubicin—thyroid cancer	0.000311	0.000412	CcSEcCtD
Darunavir—Constipation—Doxorubicin—thyroid cancer	0.000311	0.000412	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—thyroid cancer	0.000311	0.000411	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—thyroid cancer	0.000311	0.000411	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—thyroid cancer	0.0003	0.000397	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000297	0.000394	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—thyroid cancer	0.00029	0.000383	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—thyroid cancer	0.000289	0.000382	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—thyroid cancer	0.000288	0.00038	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—thyroid cancer	0.000288	0.00038	CcSEcCtD
Darunavir—Asthenia—Epirubicin—thyroid cancer	0.000282	0.000373	CcSEcCtD
Darunavir—Pruritus—Epirubicin—thyroid cancer	0.000278	0.000368	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—thyroid cancer	0.000269	0.000356	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—thyroid cancer	0.000268	0.000355	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—thyroid cancer	0.000261	0.000345	CcSEcCtD
Darunavir—Dizziness—Epirubicin—thyroid cancer	0.00026	0.000344	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—thyroid cancer	0.000257	0.000341	CcSEcCtD
Darunavir—Vomiting—Epirubicin—thyroid cancer	0.00025	0.000331	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—thyroid cancer	0.000249	0.000329	CcSEcCtD
Darunavir—Rash—Epirubicin—thyroid cancer	0.000248	0.000328	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—thyroid cancer	0.000248	0.000328	CcSEcCtD
Darunavir—Headache—Epirubicin—thyroid cancer	0.000246	0.000326	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—thyroid cancer	0.000241	0.000318	CcSEcCtD
Darunavir—Nausea—Epirubicin—thyroid cancer	0.000234	0.000309	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—thyroid cancer	0.000231	0.000306	CcSEcCtD
Darunavir—Rash—Doxorubicin—thyroid cancer	0.000229	0.000303	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—thyroid cancer	0.000229	0.000303	CcSEcCtD
Darunavir—Headache—Doxorubicin—thyroid cancer	0.000228	0.000302	CcSEcCtD
Darunavir—Nausea—Doxorubicin—thyroid cancer	0.000216	0.000286	CcSEcCtD
